Quick answers
- What is Optase?
- Optase is a brand name of Glycerin, an over-the-counter medicine. The FDA NDC Directory lists 6 Optase products in 5 strengths and forms.
- Who makes Optase?
- Scope Health Inc lists 6 of the 6 Optase products in the FDA NDC Directory.
- Is there a generic or store brand of Optase?
- Yes. The FDA NDC Directory lists 3 other products with the same active ingredients, strength and form as a Optase product, 3 of them generic or store brands. Ask your pharmacist whether one is right for you.
- Has Optase been recalled?
- FDA enforcement reports list 1 recall of Optase products; the newest started April 20, 2026. A recall usually concerns specific lots, not every product.
What Optase is
Each Optase product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Glycerin · over-the-counter medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| glycerin 0.25 mg/mL solution/ drops (ophthalmic) | Optase | None listed | — |
| glycerin 0.3 mg/mL solution/ drops (ophthalmic) | Optase | None listed | — |
| glycerin 1 mg/mL spray (ophthalmic) | Optase | 1 product, 1 company | — |
| glycerin 2 mg/mL solution/ drops (ophthalmic) | Optase | 2 products, 2 companies | — |
| glycerin 9 mg/mL solution/ drops (ophthalmic) | Optase | None listed | — |
Its page quotes the Drug Facts label and lists every brand and store brand: Glycerin →
FDA approval
Optase products are sold under an FDA over-the-counter monograph: rules that set the allowed active ingredients, strengths and label wording, so these products do not need an individual FDA approval.
Companies that list Optase
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Optase products.
- Scope Health Inc6 products
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
April 20, 2026 · Class II · Ongoing · D-0499-2026
Lack of Assurance of Sterility
Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01. — SCOPE HEALTH
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.